News and Blog

Navigating the complex intersection of the life sciences industry and insurance

Through engaging articles from our industry experts, learn about cutting-edge research, breakthrough discoveries, regulatory compliance, risk management strategies, and much more.

Blog content is current only as of the publication date and may become outdated as laws, regulations, and industry practices evolve. This blog is for general informational purposes only and is not intended as legal or other professional advice. Links to third party websites are provided for convenience only and do not constitute an endorsement of any third-party products, services, or opinions. Berkley Life Sciences is not responsible for the content of external sites. Views expressed are those of the individual author and do not necessarily reflect the views of any Berkley company.

What the Increase in Decentralized Clinical Trials Means for Your Business

A micropipette is used to fill a 96-well plate in a clinical laboratory

Due to the pandemic, many ongoing clinical trials have faced disruptions due to restrictions on participant travel. As a result, researchers and sponsors quickly adapted their trial protocols to incorporate remote and decentralized approaches. This led to increased adoption of DCTs across a wide range of therapeutic areas. This article discusses the development of decentralized clinical trials and how companies can benefit from their increased prevalence.